Blog
RSS FeedPosted by Michael Wonder on 30 Apr 2018
A new incentive to encourage the prescription of biosimilars
26 April 2018 - The Directorate General of Health Care Supply and the Directorate General of Social Security published a ...
Posted by Michael Wonder on 30 Apr 2018
Access to biosimilars in EU expected to continue to outpace US and Canada
27 April 2018 - Biosimilar experts from across the EU continued to show how rapidly biosimilars have gained market share, ...
Posted by Michael Wonder on 23 Apr 2018
Biosimilar education grant
23 April 2018 - A grant has been awarded to GBMA Education Limited to complement and extend the activities undertaken by ...
Posted by Michael Wonder on 19 Mar 2018
Outcome statement - Feb 2018 Drug Utilisation Sub Committee meeting
16 March 2018 - The outcome statement from the February 2018 Drug Utilisation Sub Committee meeting is now available. ...
Posted by Michael Wonder on 02 Mar 2018
PBAC Drug Utilisation Sub Committee utilisation analysis public release documents
2 March 2018 - The utilisation analysis public release documents from the September 2017 DUSC meeting are now available. ...
Posted by Michael Wonder on 01 Mar 2018
Friction in the path to use of biosimilar drugs
1 March 2018 - Enactment of the Biologics Price Competition and Innovation Act in 2010 raised expectations that new competition would ...
Posted by Michael Wonder on 21 Dec 2017
PBS expenditure and prescriptions report - 2016-17
20 December 2017 - The PBS expenditure and prescriptions report for 2016-17 is now available. ...
Posted by Michael Wonder on 14 Dec 2017
Months after approval, breakthrough cancer drug given to just five patients
14 December 2017 - No Medicare coverage, one-by-one rulings by private insurers. ...
Posted by Michael Wonder on 14 Dec 2017
Report on the collection of under co-payment data 2016-17
14 December 2017 - From 1 July 2016 to 30 June 2017, approximately 85 million under co-payment prescriptions were supplied ...
Posted by Michael Wonder on 13 Dec 2017
FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
13 February 2017 - New website streamlines how FDA updates information used to help health care providers choose an appropriate treatment ...
Posted by Michael Wonder on 11 Dec 2017
NHS advises GPs not to prescribe “low value” drugs
30 November 2017 - NHS England will issue guidance to GPs and commissioners to limit the prescribing of “low value” ...
Posted by Michael Wonder on 29 Nov 2017
Over-reliance in cardiovascular treatment – a supply risk that needs to change
29 November 2017 - New Zealand’s reliance on the cardiovascular medicines metoprolol succinate and cilazapril is out of step with ...
Posted by Michael Wonder on 23 Nov 2017
Treating hepatitis C in New Zealand
23 November 2017 - General practice has a real opportunity to significantly lead the way to treat people in the ...
Posted by Michael Wonder on 09 Nov 2017
NICE brings on board Sigma to boost med tech uptake
9 November 2017 - NICE is linking with user experience agency Sigma to develop a new system to improve the ...
Posted by Michael Wonder on 26 Oct 2017
EU scientific opinion: how to assess progress on reduction of antimicrobial resistance and antimicrobial consumption
26 October 2017 - ECDC, EFSA & EMA recommend set of indicators to measure progress in EU Member States. ...